Shenzhen - Delayed Quote CNY

Winner Medical Co., Ltd. (300888.SZ)

51.45
+1.65
+(3.31%)
At close: 3:04:34 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,674,150.20
8,977,853.63
8,185,022.06
11,351,331.55
8,037,420.81
Cost of Revenue
5,072,521.78
4,729,562.12
4,174,597.29
5,972,800.82
4,028,246.65
Gross Profit
4,601,628.42
4,248,291.51
4,010,424.77
5,378,530.73
4,009,174.17
Operating Expense
3,461,993
3,274,315.75
3,071,500.19
3,185,088.67
2,704,756.96
Operating Income
1,139,635.42
973,975.77
938,924.58
2,193,442.06
1,304,417.21
Net Non Operating Interest Income Expense
44,259.74
59,021.98
69,486.09
70,503.85
136,445.30
Pretax Income
1,018,867.05
908,348.31
749,846.27
1,919,506.10
1,462,760.51
Tax Provision
209,927.49
167,642.38
121,301.09
245,168.63
225,315.64
Net Income Common Stockholders
761,519.42
695,378.93
580,403.23
1,650,717.28
1,239,320.07
Basic EPS
1.31
1.19
0.98
2.79
2.08
Diluted EPS
1.31
1.19
0.98
2.79
2.08
Basic Average Shares
581,749.97
584,352.04
592,248.20
591,654.94
596,236.46
Diluted Average Shares
581,749.97
584,352.04
592,248.20
591,654.94
596,236.46
Total Operating Income as Reported
1,028,960.37
914,863.10
817,969.93
1,976,549.81
1,475,639.80
Rent Expense Supplemental
--
139,382.57
118,909.71
152,186
152,728.21
Total Expenses
8,534,514.78
8,003,877.86
7,246,097.48
9,157,889.49
6,733,003.61
Net Income from Continuing & Discontinued Operation
761,519.42
695,378.93
580,403.23
1,650,717.28
1,239,320.07
Normalized Income
968,279.99
885,957.46
840,386.35
1,991,722.42
1,272,747.81
Interest Income
111,546.43
117,095.21
133,913.86
123,909.56
137,983.98
Interest Expense
59,148.05
54,863.50
63,441.56
50,043.35
434.84
Net Interest Income
44,259.74
59,021.98
69,486.09
70,503.85
136,445.30
EBIT
1,078,015.10
963,211.82
813,287.84
1,969,549.44
1,463,195.36
EBITDA
1,078,015.10
1,541,418.48
1,353,678.70
2,451,287.79
1,839,908.59
Reconciled Cost of Revenue
5,072,521.78
4,729,562.12
4,174,597.29
5,972,800.82
4,028,246.65
Reconciled Depreciation
--
578,206.67
540,390.86
481,738.35
376,713.24
Net Income from Continuing Operation Net Minority Interest
761,519.42
695,378.93
580,403.23
1,650,717.28
1,239,320.07
Total Unusual Items Excluding Goodwill
-260,416.90
-233,711.76
-310,156.49
-390,937.58
-39,514.32
Total Unusual Items
-260,416.90
-233,711.76
-310,156.49
-390,937.58
-39,514.32
Normalized EBITDA
1,338,432
1,775,130.24
1,663,835.19
2,842,225.37
1,879,422.91
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-53,656.33
-43,133.23
-50,173.38
-49,932.44
-6,086.57
12/31/2021 - 9/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

301101.SZ Mingyue Optical Lens Co.,Ltd.
53.33
-0.71%
 
GXI.BE Gerresheimer AG
60.30
+0.50%
 
1ISRG.MI Intuitive Surgical, Inc.
476.35
-0.92%
 
SYNSAM.ST Synsam AB (publ)
49.85
+0.91%
 
CLPBF Coloplast A/S
99.05
0.00%
 
ALIF-B.ST AddLife AB (publ)
188.30
+0.05%
 
FIE.BE Fielmann AG
53.80
+2.28%
 
6699.HK Angelalign Technology Inc.
52.950
+1.44%
 
1066.HK WEIGAO GROUP
5.900
+0.85%
 
DYVOX.ST Dynavox Group AB (publ)
92.20
+3.13%